Back

A blood‑derived 5‑microRNA signature of atherosclerotic cardiovascular disease resilience in genetically confirmed familial hypercholesterolemia

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Lipid risk factors and prevention of cardiovascular disease Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Teresa Padro

Research Institute - Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Clinical utility of the modified controlling nutritional status score for predicting atherosclerotic severity and prognosis in statin-treated patients with atherosclerotic cardiovascular disease
Doctor N. Kuroki (JP)
Abstract
Presentation thumbnail
Association of Life’s Essential 8 and its components with adverse cardiovascular and kidney events in patients with atherosclerotic cardiovascular disease: a prospective cohort study
Mr Z. Yuan (CN)
Abstract
Presentation thumbnail
Apolipoprotein B beyond LDL-cholesterol in predicting Atherosclerotic Cardiovascular Disease risk in high-risk populations
Ms S. Demeester (US)
Abstract
Presentation thumbnail
Beyond the stent: routine vascular ultrasound after PCI reveals polyvascular extreme risk without intensified LDL‑cholesterol lowering therapy
Doctor K. Mahajan (Mandi, IN)
Abstract
Presentation thumbnail
Risk of all-cause mortality and transcontinental differences in angiopoietin-like 4 protein and lipids in patients admitted with chest pain of suspected coronary origin.
Doctor R. LEON DE LA FUENTE (Salta, AR)
Abstract

Access the full session

Session thumbnail
Lipid risk factors and prevention of cardiovascular disease

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Identifying potential mirnas and hub genes for coronary artery disease prognosis using integrative approaches
13 May 2024
thumbnail
Congress Presentation
LDL-C reduction and residual cardiovascular risk in heterozygous familial hypercholesterolemia: a matched cohort study in South Wales
1 September 2025
thumbnail
Congress Presentation
MicroRNAs in circulating microvesicles and plasma as biomarkers that complement the clinical diagnosis of diabetic dyslipidemia and its complications
30 April 2022
thumbnail
Congress Presentation
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources